| Pure Flow Processing, Sales | Number of Estimates | | | 9 | 11 | 11 | 11 |
| Pure Flow Processing, Sales | Highest | | | 512.6 | 2,087.4 | 2,221.9 | 2,338.3 |
| Pure Flow Processing, Sales | Consensus (Mean) | 469.5 | 1,953.1 | 492.5 | 2,032.5 | 2,132.8 | 2,224.2 |
| Pure Flow Processing, Sales | Median | | | 488.0 | 2,030.7 | 2,125.0 | 2,218.1 |
| Pure Flow Processing, Sales | Lowest | | | 485.1 | 2,010.0 | 2,091.0 | 2,175.0 |
| Pure Flow Processing, EBITDA before restructuring | Number of Estimates | | | 9 | 11 | 11 | 11 |
| Pure Flow Processing, EBITDA before restructuring | Highest | | | 146.1 | 582.6 | 618.6 | 654.7 |
| Pure Flow Processing, EBITDA before restructuring | Consensus (Mean) | 131.5 | 522.4 | 136.0 | 552.8 | 585.3 | 615.4 |
| Pure Flow Processing, EBITDA before restructuring | Median | | | 134.0 | 555.9 | 587.9 | 617.0 |
| Pure Flow Processing, EBITDA before restructuring | Lowest | | | 132.0 | 525.0 | 542.0 | 569.0 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Number of Estimates | | | 9 | 11 | 11 | 11 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Highest | | | 28.6 | 27.9 | 28.1 | 28.3 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Consensus (Mean) | 28.0 | 26.7 | 27.6 | 27.2 | 27.4 | 27.7 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Median | | | 27.5 | 27.4 | 27.5 | 27.8 |
| Pure Flow Processing, EBITDA before restructuring margin in % | Lowest | | | 26.5 | 25.7 | 25.5 | 25.7 |
| Nutrition Plant Engineering, Sales | Number of Estimates | | | 9 | 11 | 11 | 11 |
| Nutrition Plant Engineering, Sales | Highest | | | 495.0 | 2,111.4 | 2,248.6 | 2,406.0 |
| Nutrition Plant Engineering, Sales | Consensus (Mean) | 449.9 | 1,954.6 | 476.0 | 2,071.2 | 2,178.8 | 2,274.6 |
| Nutrition Plant Engineering, Sales | Median | | | 474.7 | 2,081.7 | 2,202.8 | 2,282.3 |
| Nutrition Plant Engineering, Sales | Lowest | | | 459.3 | 2,004.0 | 2,070.0 | 2,132.0 |
| Nutrition Plant Engineering, EBITDA before restructuring | Number of Estimates | | | 9 | 11 | 11 | 11 |
| Nutrition Plant Engineering, EBITDA before restructuring | Highest | | | 59.4 | 253.4 | 279.8 | 309.3 |
| Nutrition Plant Engineering, EBITDA before restructuring | Consensus (Mean) | 45.2 | 222.4 | 50.8 | 242.7 | 261.0 | 278.3 |
| Nutrition Plant Engineering, EBITDA before restructuring | Median | | | 49.8 | 243.9 | 264.8 | 279.7 |
| Nutrition Plant Engineering, EBITDA before restructuring | Lowest | | | 47.2 | 223.0 | 235.0 | 247.9 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Number of Estimates | | | 9 | 11 | 11 | 11 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Highest | | | 12.0 | 12.0 | 12.5 | 13.3 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Consensus (Mean) | 10.0 | 11.4 | 10.7 | 11.7 | 12.0 | 12.2 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Median | | | 10.5 | 11.8 | 12.0 | 12.3 |
| Nutrition Plant Engineering, EBITDA before restructuring margin in % | Lowest | | | 10.0 | 11.1 | 11.3 | 11.4 |
| Pharma & Food Applications, Sales | Number of Estimates | | | 9 | 11 | 11 | 11 |
| Pharma & Food Applications, Sales | Highest | | | 279.2 | 1,132.0 | 1,212.6 | 1,354.4 |
| Pharma & Food Applications, Sales | Consensus (Mean) | 262.2 | 1,058.3 | 274.3 | 1,113.8 | 1,174.3 | 1,239.2 |
| Pharma & Food Applications, Sales | Median | | | 274.0 | 1,116.2 | 1,180.7 | 1,239.7 |
| Pharma & Food Applications, Sales | Lowest | | | 268.3 | 1,090.2 | 1,139.0 | 1,184.9 |
| Pharma & Food Applications, EBITDA before restructuring | Number of Estimates | | | 9 | 11 | 11 | 11 |
| Pharma & Food Applications, EBITDA before restructuring | Highest | | | 39.7 | 164.0 | 179.0 | 196.3 |
| Pharma & Food Applications, EBITDA before restructuring | Consensus (Mean) | 34.6 | 140.7 | 37.3 | 155.9 | 169.5 | 183.3 |
| Pharma & Food Applications, EBITDA before restructuring | Median | | | 37.6 | 157.8 | 173.6 | 188.1 |
| Pharma & Food Applications, EBITDA before restructuring | Lowest | | | 35.0 | 138.0 | 144.0 | 158.0 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Number of Estimates | | | 9 | 11 | 11 | 11 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Highest | | | 14.5 | 14.5 | 15.1 | 15.5 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Consensus (Mean) | 13.2 | 13.3 | 13.6 | 14.0 | 14.4 | 14.8 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Median | | | 13.6 | 14.2 | 14.8 | 15.2 |
| Pharma & Food Applications, EBITDA before restructuring margin in % | Lowest | | | 12.8 | 12.6 | 12.6 | 13.3 |
| Farm Technologies, Sales | Number of Estimates | | | 9 | 11 | 11 | 11 |
| Farm Technologies, Sales | Highest | | | 207.8 | 821.0 | 878.8 | 935.9 |
| Farm Technologies, Sales | Consensus (Mean) | 182.3 | 763.4 | 194.9 | 804.0 | 841.1 | 875.4 |
| Farm Technologies, Sales | Median | | | 195.1 | 805.0 | 837.0 | 871.9 |
| Farm Technologies, Sales | Lowest | | | 183.3 | 783.3 | 805.7 | 825.9 |
| Farm Technologies, EBITDA before restructuring | Number of Estimates | | | 9 | 11 | 11 | 11 |
| Farm Technologies, EBITDA before restructuring | Highest | | | 34.1 | 134.6 | 149.6 | 163.6 |
| Farm Technologies, EBITDA before restructuring | Consensus (Mean) | 26.3 | 113.0 | 30.7 | 127.4 | 135.9 | 144.8 |
| Farm Technologies, EBITDA before restructuring | Median | | | 30.1 | 127.0 | 134.7 | 146.0 |
| Farm Technologies, EBITDA before restructuring | Lowest | | | 28.0 | 119.2 | 124.1 | 130.1 |
| Farm Technologies, EBITDA before restructuring margin in % | Number of Estimates | | | 9 | 11 | 11 | 11 |
| Farm Technologies, EBITDA before restructuring margin in % | Highest | | | 17.0 | 16.5 | 17.3 | 17.5 |
| Farm Technologies, EBITDA before restructuring margin in % | Consensus (Mean) | 14.4 | 14.8 | 15.7 | 15.9 | 16.2 | 16.5 |
| Farm Technologies, EBITDA before restructuring margin in % | Median | | | 16.0 | 16.0 | 16.2 | 16.6 |
| Farm Technologies, EBITDA before restructuring margin in % | Lowest | | | 14.5 | 14.8 | 14.8 | 14.9 |
| Consolidation/Other, Sales | Number of Estimates | | | 9 | 11 | 11 | 11 |
| Consolidation/Other, Sales | Highest | | | -52.2 | -230.0 | -220.0 | -215.0 |
| Consolidation/Other, Sales | Consensus (Mean) | -52.1 | -234.0 | -57.1 | -237.3 | -241.5 | -246.6 |
| Consolidation/Other, Sales | Median | | | -58.0 | -234.0 | -240.0 | -240.0 |
| Consolidation/Other, Sales | Lowest | | | -60.0 | -250.0 | -262.1 | -280.0 |
| Consolidation/Other, EBITDA before restructuring | Number of Estimates | | | 9 | 11 | 11 | 11 |
| Consolidation/Other, EBITDA before restructuring | Highest | | | -11.0 | -51.0 | -43.0 | -43.0 |
| Consolidation/Other, EBITDA before restructuring | Consensus (Mean) | -20.9 | -91.1 | -20.7 | -89.6 | -90.5 | -91.9 |
| Consolidation/Other, EBITDA before restructuring | Median | | | -21.0 | -90.5 | -90.5 | -92.7 |
| Consolidation/Other, EBITDA before restructuring | Lowest | | | -26.4 | -111.0 | -115.0 | -120.0 |